Free tool
FAERS Monitor: Khindivi
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 218980 or its brand name (Khindivi, Hydrocortisone). Reports on generic versions are filed under their own applications.
Reports
68,202
Serious
56,400
83% of reports
Hospitalization
29,026
Death reported
10,069
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- off label use9,685
- drug ineffective7,637
- fatigue6,088
- condition aggravated5,564
- nausea5,128
- rash5,024
- diarrhoea4,563
- headache4,524
- pain4,511
- dyspnoea4,399
- arthralgia4,389
- pyrexia4,050
- vomiting4,002
- pruritus3,827
- malaise3,696
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 437 |
| 2005 | 555 |
| 2006 | 511 |
| 2007 | 547 |
| 2008 | 613 |
| 2009 | 735 |
| 2010 | 847 |
| 2011 | 1,083 |
| 2012 | 1,768 |
| 2013 | 1,542 |
| 2014 | 1,779 |
| 2015 | 2,440 |
| 2016 | 2,886 |
| 2017 | 3,318 |
| 2018 | 4,828 |
| 2019 | 4,318 |
| 2020 | 5,259 |
| 2021 | 5,485 |
| 2022 | 6,149 |
| 2023 | 6,108 |
| 2024 | 6,436 |
| 2025 | 6,229 |
| 2026 | 4,325 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,985,957 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| condition aggravatedSignal | 5,564 | 5.7 | 5.6 | 21,637 |
| pyrexiaSignal | 4,050 | 3.6 | 3.5 | 7,791 |
| rashSignal | 5,024 | 3.6 | 3.5 | 9,446 |
| off label useSignal | 9,685 | 3.4 | 3.4 | 17,275 |
| arthralgiaSignal | 4,389 | 3.3 | 3.2 | 7,017 |
| pruritusSignal | 3,827 | 3.1 | 3.0 | 5,460 |
| vomitingSignal | 4,002 | 2.6 | 2.6 | 4,130 |
| malaiseSignal | 3,696 | 2.6 | 2.5 | 3,723 |
| fatigueSignal | 6,088 | 2.4 | 2.4 | 5,239 |
| dyspnoeaSignal | 4,399 | 2.4 | 2.3 | 3,689 |
| painSignal | 4,511 | 2.3 | 2.2 | 3,291 |
| headacheSignal | 4,524 | 2.2 | 2.2 | 3,155 |
| diarrhoeaSignal | 4,563 | 2.2 | 2.1 | 3,015 |
| nauseaSignal | 5,128 | 2.0 | 2.0 | 2,664 |
| drug ineffective | 7,637 | 1.8 | 1.8 | 2,833 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.